NEW YORK, NY — March 3, 2002 — Patients with allergic rhinitis appear to prefer budesonide aqeuous nasal spray over fluticasone propionate nasal spray based on their perception of specific sensory attributes for both products.
Researchers announced their survey findings here today at the 58th Annual Meeting of the American Academy of Allergy, Asthma, and Immunology (AAAAI).
Budesonide aqueous nasal spray (BANS) is an unscented, benzalkonium chloride-free intranasal corticosteroid (INCS) formulation. Fluticasone propionate nasal spray (FPPS) contains BKC, which is an excipient known to have a bitter taste….
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!